von Frijtag Drabbe Künzel JK - Search Results

1

Partial agonism of theophylline-7-riboside on adenosine receptors.

IJzerman AP, van der Wenden EM, von Frijtag Drabbe Künzel JK, Mathôt RA, Danhof M, Borea PA, Varani K. IJzerman AP, et al. Naunyn Schmiedebergs Arch Pharmacol. 1994 Dec;350(6):638-45. doi: 10.1007/BF00169369. Naunyn Schmiedebergs Arch Pharmacol. 1994. PMID: 7708121

2

N6,C8-distributed adenosine derivatives as partial agonists for adenosine A1 receptors.

Roelen H, Veldman N, Spek AL, von Frijtag Drabbe Künzel J, Mathôt RA, IJzerman AP. Roelen H, et al. J Med Chem. 1996 Mar 29;39(7):1463-71. doi: 10.1021/jm950267m. J Med Chem. 1996. PMID: 8691477

3

Ribose-modified adenosine analogues as potential partial agonists for the adenosine receptor.

van der Wenden EM, von Frijtag Drabbe Künzel JK, Mathôt RA, Danhof M, IJzerman AP, Soudijn W. van der Wenden EM, et al. J Med Chem. 1995 Sep 29;38(20):4000-6. doi: 10.1021/jm00020a014. J Med Chem. 1995. PMID: 7562934

4

8-substituted adenosine and theophylline-7-riboside analogues as potential partial agonists for the adenosine A1 receptor.

Van der Wenden EM, Hartog-Witte HR, Roelen HC, von Frijtag Drabbe Künzel JK, Pirovano IM, Mathôt RA, Danhof M, Van Aerschot A, Lidaks MJ, IJzerman AP, et al. Van der Wenden EM, et al. Eur J Pharmacol. 1995 Aug 15;290(3):189-99. doi: 10.1016/0922-4106(95)00064-x. Eur J Pharmacol. 1995. PMID: 7589213

5

Site-directed mutagenesis of the human adenosine A2A receptor. Critical involvement of Glu13 in agonist recognition.

IJzerman AP, Von Frijtag Drabbe Künzel JK, Kim J, Jiang Q, Jacobson KA. IJzerman AP, et al. Eur J Pharmacol. 1996 Aug 29;310(2-3):269-72. doi: 10.1016/0014-2999(96)00495-5. Eur J Pharmacol. 1996. PMID: 8884226 Free PMC article.

6

5'-substituted adenosine analogs as new high-affinity partial agonists for the adenosine A1 receptor.

van der Wenden EM, Carnielli M, Roelen HC, Lorenzen A, von Frijtag Drabbe Künzel JK, IJzerman AP. van der Wenden EM, et al. J Med Chem. 1998 Jan 1;41(1):102-8. doi: 10.1021/jm970508l. J Med Chem. 1998. PMID: 9438026

7

Time course of action of three adenosine A1 receptor agonists with differing lipophilicity in rats: comparison of pharmacokinetic, haemodynamic and EEG effects.

van Schaick EA, Kulkarni C, von Frijtag Drabbe Künzel JK, Mathôt RA, Cristalli G, IJzerman AP, Danhof M. van Schaick EA, et al. Naunyn Schmiedebergs Arch Pharmacol. 1997 Dec;356(6):827-37. doi: 10.1007/pl00005124. Naunyn Schmiedebergs Arch Pharmacol. 1997. PMID: 9453470

8

N6-cyclopentyl-2-(3-phenylaminocarbonyltriazene-1-yl)adenosine (TCPA), a very selective agonist with high affinity for the human adenosine A1 receptor.

Beukers MW, Wanner MJ, Von Frijtag Drabbe Künzel JK, Klaasse EC, IJzerman AP, Koomen GJ. Beukers MW, et al. J Med Chem. 2003 Apr 10;46(8):1492-503. doi: 10.1021/jm021074j. J Med Chem. 2003. PMID: 12672250

9

Allosteric modulation, thermodynamics and binding to wild-type and mutant (T277A) adenosine A1 receptors of LUF5831, a novel nonadenosine-like agonist.

Heitman LH, Mulder-Krieger T, Spanjersberg RF, von Frijtag Drabbe Künzel JK, Dalpiaz A, IJzerman AP. Heitman LH, et al. Among authors: von frijtag drabbe kunzel jk. Br J Pharmacol. 2006 Mar;147(5):533-41. doi: 10.1038/sj.bjp.0706655. Br J Pharmacol. 2006. PMID: 16444290 Free PMC article.

10

2,5'-Disubstituted adenosine derivatives: evaluation of selectivity and efficacy for the adenosine A(1), A(2A), and A(3) receptor.

van Tilburg EW, von Frijtag Drabbe Kunzel J, de Groote M, IJzerman AP. van Tilburg EW, et al. J Med Chem. 2002 Jan 17;45(2):420-9. doi: 10.1021/jm010952v. J Med Chem. 2002. PMID: 11784146

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters